Automatic bronchus and artery analysis on chest computed tomography to evaluate the effect of inhaled hypertonic saline in children aged 3-6 years with cystic fibrosis in a randomized clinical trial
Journal of Cystic Fibrosis · 2023
DOI: 10.1016/j.jcf.2023.05.013 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Journal of Cystic Fibrosis, 2023. Verfasst von Yuxin Chen und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Paediatrics, Division of Respiratory Medicine and Allergology, Sophia Children's Hospital, Erasmus MC, Rotterdam, The Netherlands; Depa…. Hauptthemen laut MEDLINE: Cystic Fibrosis. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Cystic Fibrosis Foundation, Choquette Family Foundation, Cystic Fibrosis Foundation Therapeutics Inc.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
BACKGROUND: SHIP-CT showed that 48-week treatment with inhaled 7% hypertonic saline (HS) reduced airway abnormalities on chest CT using the manual PRAGMA-CF method relative to isotonic saline (IS) in children aged 3-6 years with cystic fibrosis (CF). An algorithm was developed and validated to automatically measure bronchus and artery (BA) dimensions of BA-pairs on chest CT. Aim of the study was to assess the effect of HS on bronchial wall thickening and bronchial widening using the BA-analysis. METHODS: The BA-analysis (LungQ, version 2.1.0.1, Thirona, Netherlands) automatically segments the bronchial tree and identifies the segmental bronchi (G0) and distal generations (G1-G10). Dimensions of each BA-pair are measured: diameters of bronchial outer wall (Bout), bronchial inner wall (Bin), bronchial wall thickness (Bwt), and artery (A). BA-ratios are computed: Bout/A and Bin/A to detect bronchial widening and Bwt/A and Bwa/Boa (=bronchial wall area/bronchial outer area) to detect bronchial wall thickening. RESULTS: 113 baseline and 102 48-week scans of 115 SHIP-CT participants were analysed. LungQ measured at baseline and 48-weeks respectively 6,073 and 7,407 BA-pairs in the IS-group and 6,363 and 6,840 BA-pairs in the HS-group. At 48 weeks, Bwt/A (mean difference 0.011; 95%CI, 0.0017 to 0.020) and Bwa/Boa (mean difference 0.030; 95% 0.009 to 0.052) was significantly higher (worse) in the IS-group compared to the HS-group representing more severe bronchial wall thickening in the IS-group (p=0.025 and p=0.019 respectively). Bwt/A and Bwa/Boa decreased and Bin/A remained stable from baseline to 48 weeks in the HS while it declined in the IS-group (all p
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Paediatrics, Division of Respiratory Medicine and Allergology, Sophia Children's Hospital, Erasmus MC, Rotterdam, The Netherlands; Department of Radiology and Nuclear Medicine, Erasmus MC, Rotterdam, The N…
- Department of Biostatistics, Erasmus MC, Rotterdam, The Netherlands; Department of Epidemiology, Erasmus MC, Rotterdam, The Netherlands.
- Thirona, Nijmegen, The Netherlands.
- Department of Paediatrics, Division of Respiratory Medicine and Allergology, Sophia Children's Hospital, Erasmus MC, Rotterdam, The Netherlands; Wal-yan Respiratory Research Centre, Telethon Kids Institute, Perth, Austr…
- Department of Pediatrics, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, United States.
- Seattle Children's Research Institute, Seattle, WA, United States.
Förderung
- Cystic Fibrosis Foundation
- Choquette Family Foundation
- Cystic Fibrosis Foundation Therapeutics Inc
- Telethon Kids Institute
- Chiesi Farmaceutici
- National Health and Medical Research Council
- Erasmus Medisch Centrum
- National Institutes of Health
Zitieren
APA
Chen, Y., Lv, Q., Andrinopoulou, E. R., Gallardo-Estrella, L., Charbonnier, J. P., Caudri, D., Davis, S. D., Rosenfeld, M., Ratjen, F., Kronmal, R. A., Stukovsky, K. D. H., Stick, S., Tiddens, H. A. W. M., & on behalf the SHIP-CT study group (2023). Automatic bronchus and artery analysis on chest computed tomography to evaluate the effect of inhaled hypertonic saline in children aged 3-6 years with cystic fibrosis in a randomized clinical trial. Journal of Cystic Fibrosis. https://doi.org/10.1016/j.jcf.2023.05.013
Vancouver
Chen Y, Lv Q, Andrinopoulou ER, Gallardo-Estrella L, Charbonnier JP, Caudri D, et al. Automatic bronchus and artery analysis on chest computed tomography to evaluate the effect of inhaled hypertonic saline in children aged 3-6 years with cystic fibrosis in a randomized clinical trial. Journal of Cystic Fibrosis. 2023. doi:10.1016/j.jcf.2023.05.013
BibTeX
@article{Chen2023,
author = {Chen, Yuxin and Lv, Qianting and Andrinopoulou, Eleni-Rosalina and Gallardo-Estrella, Leticia and Charbonnier, Jean-Paul and Caudri, Daan and Davis, Stephanie D and Rosenfeld, Margaret and Ratjen, Felix and Kronmal, Richard A and Stukovsky, Karen D Hinckley and Stick, Stephen and Tiddens, Harm A W M and on behalf the SHIP-CT study group, on behalf the SHIP-CT study group},
title = {Automatic bronchus and artery analysis on chest computed tomography to evaluate the effect of inhaled hypertonic saline in children aged 3-6 years with cystic fibrosis in a randomized clinical trial},
journal = {Journal of Cystic Fibrosis},
year = {2023},
doi = {10.1016/j.jcf.2023.05.013}
}
EUVIMED